Altogether, our data show that the induction of integrin α5 expression might represent one of the mechanisms through which FoxO3a restores the tumor response to antiestrogen treatment, confirming that the transcription factor might represent a pursuable target to be exploited in endocrine-resistant tumors. The gene discussed is FOXO3; the disease is neoplasm.